[PLX] YoY Quarter Result on 31-Mar-2009 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
11-May-2009
Financial Year
2009
Quarter
31-Mar-2009 [#Q1]
Profit Trend
QoQ- 21.18%
YoY- -1.37%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Revenue 3,728 6,000 1,141 0 0 0 0 -
PBT 0 -5,052 -7,955 0 -1,150 -331 0 -
Tax -161 0 0 148 -1,150 3,119 11 -
NP -5,904 -5,052 -7,955 -5,183 -5,113 -3,450 -11 184.80%
Tax Rate - - - - - - - -
Total Cost 9,632 11,052 9,096 5,183 5,113 3,450 11 208.98%
Ratio Analysis
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
NP Margin -158.37 -84.20 -697.20 0.00 0.00 0.00 0.00 -
Per Share
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
EPS -0.07 -0.06 -0.10 -0.07 -0.07 -0.54 -0.00 -
EPS Diluted -0.07 -0.06 -0.10 -0.07 -0.07 -0.54 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.